期刊论文详细信息
BMC Infectious Diseases
Dynamics of serotype 14 Streptococcus pneumoniae population causing acute respiratory infections among children in China (1997–2012)
Yonghong Yang1  Sangjie Yu1  Lin Yuan1  Wei Gao1  Wei Shi1  Kaihu Yao1  Mingming He1 
[1] Key Laboratory of Major Diseases in Children and National Key Discipline of Pediatrics, Ministry of Education, Beijing Pediatric Research Institute, Beijing Children’s Hospital Affiliated to Capital Medical University, Beijing, P. R. China
关键词: Epidemiology;    Children;    Antibiotic resistance;    Serotypes;    Streptococcus pneumoniae;   
Others  :  1230433
DOI  :  10.1186/s12879-015-1008-7
 received in 2014-10-31, accepted in 2015-07-06,  发布年份 2015
PDF
【 摘 要 】

Background

In the last decade, the Streptococcus pneumoniae population has changed, mainly due to the abuse of antibiotics. The aim of this study was to determine the genetic structure of 144 S. pneumonia serotype 14 isolates collected from children with acute respiratory infections during 1997–2012 in China.

Methods

All isolated pneumococci were tested for their sensitivity to 11 kinds of antibiotics with the E-test method or disc diffusion. The macrolides resistance genes ermB and mefA, as well as the sulfamethoxazole-trimethoprim resistance gene dihydrofolate reductase (DHFR) were detected by polymerase chain reaction (PCR). The sequence types (STs) were analyzed with multilocus sequence typing (MLST).

Results

From 1997 to 2012, the percentage of serotype 14 S. pneumonia isolates in the whole isolates increased. All of the 144 serotype 14 S. pneumonia isolates were susceptible to amoxicillin-clavulanic acid, vancomycin and levofloxacin. No penicillin resistant isolate was found, and the intermediate rate was as low as 0.7 %. Erythromycin resistance was confirmed among 143 isolates. The ermB gene was determined in all erythromycin resistant isolates, and the mefA gene was positive additionally in 13 of them. The non-susceptibility rate to the tested cephalosporins increased from 1997–2012. All trimethoprim-resistant isolates contained the Ile100-Leu mutation. Overall, 30 STs were identified, among which ST876 was the most prevalent, followed by ST875. During the study period, the percentage of CC876 increased from 0 % in 1997–2000 to 96.4 % in 2010–2012, whereas CC875 decreased from 84.2 to 0 %. CC876 showed higher non-susceptibility rates to β-lactam antibiotics than CC875.

Conclusion

The percentage of serotype 14 S. pneumonia isolates increased over time in China. The increase of resistance to β-lactam antibiotics in this serotype isolates was associated with the spread of CC876.

【 授权许可】

   
2015 He et al.

【 预 览 】
附件列表
Files Size Format View
20151106065829529.pdf 698KB PDF download
Fig. 3. 27KB Image download
Fig. 2. 21KB Image download
Fig. 1. 15KB Image download
【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

【 参考文献 】
  • [1]Pneumococcal conjugate vaccine for childhood immunization--WHO position paper. Wkly Epidemiol Rec. 2007; 82:93-104.
  • [2]Kattan R, Abu Rayyan A, Zheiman I, Idkeidek S, Baraghithi S, Rishmawi N et al.. Serotype distribution and drug resistance in Streptococcus pneumoniae, Palestinian Territories. Emerg Infect Dis. 2011; 17:94-6.
  • [3]Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH et al.. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother. 2004; 48:2101-7.
  • [4]Jauneikaite E, Jefferies JM, Hibberd ML, Clarke SC. Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review. Vaccine. 2012; 30:3503-14.
  • [5]Dagan R, Klugman KP. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis. 2008; 8:785-95.
  • [6]Feikin DR, Klugman KP. Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. Clin Infect Dis. 2002; 35:547-55.
  • [7]García-Suárez Mdel M, Villaverde R, Caldevilla AF, Méndez FJ, Vázquez F. Serotype distribution and antimicrobial resistance of invasive and non-invasive pneumococccal isolates in Asturias, Spain. Jpn J Infect Dis. 2006; 59:299-305.
  • [8]Liu C, Xiong X, Xu W, Sun J, Wang L, Li J. Serotypes and patterns of antibiotic resistance in strains causing invasive pneumococcal disease in children less than 5 years of age. PLoS One. 2013; 8:e54254.
  • [9]Li QH, Yao KH, Yu SJ, Ma X, He MM, Shi W et al.. Spread of multidrug-resistant clonal complex 271 of serotype 19 F Streptococcus pneumoniae in Beijing, China: characterization of serotype 19 F. Epidemiol Infect. 2013; 141:2492-6.
  • [10]Ma X, Yao KH, Yu SJ, Zhou L, Li QH, Shi W et al.. Genotype replacement within serotype 23 F Streptococcus pneumoniae in Beijing, China: characterization of serotype 23 F. Epidemiol Infect. 2013; 141:1690-6.
  • [11]Li J, Yang YH, Yu SJ, Yuan L, Hu YY. Study on resistance to antibiotics to Streptococcus pneumoniae. Zhonghua Erke Zazhi. 2011; 37:408-11.
  • [12]Xue L, Yao K, Xie G, Zheng Y, Wang C, Shang Y et al.. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates that cause invasive disease among Chinese children. Clin Infect Dis. 2010; 50:741-4.
  • [13]Yao K, Shen X, Yu S, Lu Q, Deng L, Ye Q et al.. Antimicrobial resistance and serotypes of nasopharyngeal strains of Streptococcus pneumoniae in Chinese children with acute respiratory infections. J Int Med Res. 2007; 35:253-67.
  • [14]Yao KH, Wang LB, Zhao GM, Zheng YJ, Deng L. Study on antimicrobial resistance in different serotypes of Streptococcus pneumoniae isolated from pediatric patients hospitalized for pneumonia. Linchuang Erke Zazhi. 2009; 27:524-7.
  • [15]Yu J, Carvalho Mda G, Beall B, Nahm MH. A rapid pneumococcal serotyping system based on monoclonal antibodies and PCR. J Med Microbiol. 2008; 57:171-8.
  • [16]Ma X, Zhao R, Ma Z, Yao K, Yu S, Zheng Y et al.. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing invasive diseases from Shenzhen children’s hospital. PLoS One. 2013; 8:e67507.
  • [17]Kelly LM, Jacobs MR, Appelbaum PC. Comparison of agar dilution, microdilution, E-test, and disk diffusion methods for testing activity of cefditoren against Streptococcus pneumoniae. J Clin Microbiol. 1999; 37:3296-9.
  • [18]Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement, M100-S22. CLSI, Wayne, PA; 2012.
  • [19]Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother. 1996; 40:2562-6.
  • [20]Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology. 1998; 144:3049-60.
  • [21]Maskell JP, Sefton AM, Hall LM. Multiple mutations modulate the function of dihydrofolate reductase in trimethoprim-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother. 2001; 45:1104-8.
  • [22]Yao KH, Yang YH. Streptococcus pneumoniae diseases in Chinese children: past, present and future. Vaccine. 2008; 26:4425-33.
  • [23]Liu Y, Wang H, Chen M, Sun Z, Zhao R, Zhang L et al.. Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years. Diagn Microbiol Infect Dis. 2008; 61:256-63.
  • [24]Antonio M, Dada-Adegbola H, Biney E, Awine T, O’Callaghan J, Pfluger V et al.. Molecular epidemiology of pneumococci obtained from Gambian children aged 2–29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine. BMC Infect Dis. 2008; 8:81. BioMed Central Full Text
  • [25]Denham BC, Clarke SC. Serotype incidence and antibiotic susceptibility of Streptococcus pneumoniae causing invasive disease in Scotland, 1999–2002. J Med Microbiol. 2005; 54:327-31.
  • [26]Zhang W, Shen X, Wang Y, Chen Y, Huang M, Zeng Q et al.. Antibiotic use in five children’s hospitals during 2002–2006: the impact of antibiotic guidelines issued by the Chinese Ministry of Health. Pharmacoepidemiol Drug Saf. 2008; 17:306-11.
  • [27]Adrian PV, Klugman KP. Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1997; 41:2406-13.
  • [28]Pikis A, Donkersloot JA, Rodriguez WJ, Keith JM. A conservative amino acid mutation in the chromosome-encoded dihydrofolate reductase confers trimethoprim resistance in Streptococcus pneumoniae. J Infect Dis. 1998; 178:700-6.
  文献评价指标  
  下载次数:49次 浏览次数:29次